Combination therapy may offer better outcomes for patients with retinoblastoma

Posted by on April 15, 2016 1:24 pm
Categories: health

Targeting survivin — a protein that inhibits apoptosis or cell death — enhances the effectiveness of chemotherapy in cells and mouse models of retinoblastoma (Rb), the most common malignant tumor of the eye in children, researchers report.

Leave a Reply

Your email address will not be published. Required fields are marked *